Approval · Notice of Compliance 23676 · 2020
KUVAN: Notice of Compliance 23676
Issued May 27, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23676
- Date
- May 27, 2020
- Company
- Biomarin International LimitedRingaskiddy, Cork, Ireland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Changes to the inner and outer labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KUVAN | Not yet assigned | — |
Medicinal ingredients
- SAPROPTERIN DIHYDROCHLORIDE 100 MG per PCK
- SAPROPTERIN DIHYDROCHLORIDE 500 MG per PCK